Filter
Exclude
Time range
-
Near
💡 #PULSAR: Investing in the Ethical and Predictive Future of Health PULSAR: Deep Tech, Polyomic AI, and Tokenized Transparency for a 12-Year Predictive Advantage 🧬💰🕌  The global health crisis demands a radical shift: from reaction to prediction. PULSAR is leading this transformation, merging cutting-edge science with ethical, transparent, and scalable financial infrastructure.  🧠 The Engine of Prediction: Polyomic Biopredictive AI Our strategic asset is a proprietary Deep Learning algorithm designed to decode biological complexity:  - Comprehensive Polyomic Analysis: Beyond genomics, our AI integrates all omic layers (genome, metabolome, proteome, and longitudinal environmental factors).  - Unmatched Advantage: We anticipate the risk of chronic diseases up to 12 years before clinical manifestation.  - Tokenized IP: We invest in our Dry Lab (tokenized intellectual property) while outsourcing the Wet Lab (sequencing), maximizing predictive power with capital efficiency.  🌐 Scalability and B2B2C Revenue Model We have designed a model that combines institutional profitability with citizen participation:  - Revenue Generator (B2B): Insurers and Health Administrators access our Risk Dashboard via SaaS licensing, transforming reactive spending into proactive investment.  - Data Generator (B2C): End users are incentivized with tokens to share anonymous longitudinal data through PULSAR wearables, ensuring a continuous flow that enhances AI accuracy.  🔗 Sidrachain: Ethical Governance and Tokenized Transparency Built on Sidrachain, PULSAR guarantees financial integrity and access to the global ethical investment market:  - Capital Tokenization: Investment is conducted through Security Tokens, eliminating interest-based debt (Riba).  - Certified Transparency: Our model is Sharia-Compliant (Fatwa certified), validating transparency and eliminating uncertainty (Gharar).  ✨ PULSAR offers investors a unique opportunity: to participate in a Deep Tech asset that combines predictive science, scalable B2B2C economics, and ethical governance.  Invest in PULSAR. Invest in the only advantage that truly matters: time.  sidrastart.com/project/2c8f8… #PULSAR #DeepTech #PredictiveAI #Polyomics #Tokenization #Sidrachain #EthicalInvestment
2
12
25
703
💡 #PULSAR: Investing in the Ethical and Predictive Future of Health #PULSAR: Deep Tech, Polyomic AI, and Tokenized Transparency for a 12-Year Predictive Advantage 🧬💰🕌  The global health crisis demands a radical shift: from reaction to prediction. PULSAR is leading this transformation, merging cutting-edge science with ethical, transparent, and scalable financial infrastructure.  🧠 The Engine of Prediction: Polyomic Biopredictive AI Our strategic asset is a proprietary Deep Learning algorithm designed to decode biological complexity:  - Comprehensive Polyomic Analysis: Beyond genomics, our AI integrates all omic layers (genome, metabolome, proteome, and longitudinal environmental factors).  - Unmatched Advantage: We anticipate the risk of chronic diseases up to 12 years before clinical manifestation.  - Tokenized IP: We invest in our Dry Lab (tokenized intellectual property) while outsourcing the Wet Lab (sequencing), maximizing predictive power with capital efficiency.  🌐 Scalability and B2B2C Revenue Model We have designed a model that combines institutional profitability with citizen participation:  - Revenue Generator (B2B): Insurers and Health Administrators access our Risk Dashboard via SaaS licensing, transforming reactive spending into proactive investment.  - Data Generator (B2C): End users are incentivized with tokens to share anonymous longitudinal data through PULSAR wearables, ensuring a continuous flow that enhances AI accuracy.  🔗 Sidrachain: Ethical Governance and Tokenized Transparency Built on Sidrachain, PULSAR guarantees financial integrity and access to the global ethical investment market:  - Capital Tokenization: Investment is conducted through Security Tokens, eliminating interest-based debt (Riba).  - Certified Transparency: Our model is Sharia-Compliant (Fatwa certified), validating transparency and eliminating uncertainty (Gharar).  ✨ PULSAR offers investors a unique opportunity: to participate in a Deep Tech asset that combines predictive science, scalable B2B2C economics, and ethical governance.  Invest in PULSAR. Invest in the only advantage that truly matters: time.  sidrastart.com/project/2c8f8… @XidraBaytRoyale @GLNsGlobal @REGsTrading @Sidraholding @sidrachain @maljefairi @Fawadsaddat11 @wreixidra #PULSAR #DeepTech #PredictiveAI #Polyomics #Tokenization #Sidrachain #EthicalInvestment
1
11
21
1,998
🚀 #PULSAR: Breaking the Paradigm with #Polyomic Science PULSAR is the future of wellbeing: the world’s first Sharia-compliant predictive health intelligence engine. We are leaving reactive medicine behind and entering the era of predictive health assurance 🔬 The Heart of PULSAR: Polyomic Intelligence Our biopredictive AI goes far beyond an annual check-up. PULSAR integrates a cutting-edge Polyomic approach, combining: - Genomics: Your biological potential.  - Proteomics & Metabolomics: Your current biological state and how it responds to the environment.  - Lifestyle Data: How you live, move, sleep, and make decisions. This convergence of multiple layers of data —Polyomics— allows us to build hyper-personalized health models capable of detecting risk signals 7 to 12 years before a disease appears.  It is predictive science in service of life preservation. 🔒 Protecting Your Omic Data Is a Sacred Duty (Hurma al-Khass) At PULSAR, privacy is not a technical requirement — it is an ethical mandate. To protect your Hurma al-Khass (individual privacy): - Homomorphic Encryption: Your polyomic data remains encrypted even while being analyzed.  - Federated Learning: The model learns without your raw data ever leaving its origin. Only “lessons” travel, never the data itself. Your biology is sacred. And we treat it as such. 🤝 The PULSAR Model: Strategic B2B2C PULSAR is a tokenized startup powered by SidraChain, designed as a transformative solution for Employers and Insurers: - Drastic cost reduction by preventing chronic diseases before they emerge.  - Human optimization, longevity, and sustainable wellbeing.  - Ethical infrastructure, transparent and aligned with Sharia principles. PULSAR is the divine convergence of medicine, AI, and ethics.  We are moving healthcare from reaction… to the proactive preservation of life. ➡️ PULSAR is a major opportunity to join the revolution of predictive medicine.  If you want to be part of this historic transformation, you can invest through this link. sidrastart.com/project/2c8f8… #PULSAR #Polyomics #PredictiveHealth #B2B2C #TokenizedAI #SidraChain #ShariaMedicine #EthicalAI #PredictiveWellbeing
1
8
15
425
Have you heard of Polyomic Medicine or the 4Ps Theory of Healthcare? @PillayRubin is worth following here and/or on @Substack. 👉: substack.com/home/post/p-163…
3
88
Congratulations to our @WCMCPathology Resident Julian Willett, M.D., Ph.D., on his new Alzheimer's & Dementia journal article, "Assessing polyomic risk to predict #Alzheimers disease using a #MachineLearning model." #Pathology #PathTwitter @PathSocial alz-journals.onlinelibrary.w…
1
6
600
Polyomic era is here to stay. Great and inspiring speech from @DanielAletaha #EULAR2022
Tomorrow’s challenge is not to just collect data but also to homogenise them. We need to be collaborative and focus on Digital and human - EULAR President Elect Prof Aletaha @RheumNow #EULAR2022
1
4
Here is our collection on Genomic and “Polyomic” Studies of Cardiovascular and Inflammatory Diseases journals.physiology.org/topi… #RNASequencing

Check out #PhysiologicalG's latest collections here- ow.ly/83qb50IxbH8
1
2
27 Jun 2020
Professor Norberto Lopes (University of São Paulo) is the Winner of the 2020 Jeremy Knowles Award, for his pioneering analytical and polyomic studies that inform chemical ecology and natural product modes of action. Congratulations! #LatinXChem rsc.org/awards-funding/award…

7
26
25 Jun 2020
'For pioneering analytical and polyomic studies that inform chemical ecology and natural product modes of action.'
1
1
Polyomic medicine is practising medicine at the molecular level and focuses on prevention. Precision medicine allows us to know the person the disease has instead of the disease the person has. The future of rheumatology, McInnes I #rheum #rheum2030 #acr18
1
1
6
Iain McInnes challenges us to think of Polyomic Revolution to treat rheumatic diseases....music to my ears @TheA3BC @lynmarch1 #PRES2018
3
4